Trial
NCT03239470
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Autoimmunity Centers of Excellence; Rho Federal Systems Division, Inc.
Condition
Pemphigus Foliaceus
Intervention
Cohort 1: 1.0 x 10^8 PolyTregs
Why stopped
Lack of recruitment, ongoing and new feasibility issues, and the impact of the coronavirus infectious disease 19 (COVID-19) pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-15